Home/Filings/4/0001209191-22-044006
4//SEC Filing

Brewis Neil 4

Accession 0001209191-22-044006

CIK 0001566373other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 9:07 PM ET

Size

10.8 KB

Accession

0001209191-22-044006

Insider Transaction Report

Form 4
Period: 2022-07-29
Brewis Neil
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2022-07-296,3070 total
    Exercise: $0.11Exp: 2029-05-07Common Stock (6,307 underlying)
  • Exercise/Conversion

    Common Stock

    2022-07-29$0.11/sh+76,619$8,428114,463 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2022-07-2970,3120 total
    Exercise: $0.11Exp: 2030-07-01Common Stock (70,312 underlying)
Footnotes (5)
  • [F1]This Report is reporting the exempt exercise of employee stock options for cash payment thereof and receipt of the resulting shares. No shares were sold incidental to the exercise of these stock options.
  • [F2]This exercise price was originally reported incorrectly as $0.08 per share due to a conversion rate error from Pound Sterling into U.S. Dollars. Using the August 2022 approximate exchange rate of 1.2211, the exercise price in U.S. Dollars would be approximately $0.11 per share.
  • [F3]Includes 18,000 RSUs previously reported. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  • [F4]So long as Participant remains continuously a Service Provider 28% of the total number of Shares under Award shall vest on the first anniversary of the Vesting Commencement Date, May 7, 2019, and 2% of the total number of Shares under Award shall vest monthly thereafter.
  • [F5]Twenty-five per cent (25%) of the total number of Shares under Award shall vest on the first anniversary of the Vesting Commencement Date, July 1, 2020, and two and one twelfth per cent (2.083%) of the total number of Shares under Award shall vest monthly thereafter, provided in each case that the Participant remains a Service Provider continuously from the Vesting Commencement Date to the relevant date.

Issuer

F-star Therapeutics, Inc.

CIK 0001566373

Entity typeother

Related Parties

1
  • filerCIK 0001831247

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 9:07 PM ET
Size
10.8 KB